Agrawal, Sushma. 2014. Late effects of cancer treatment in breast cancer survivors. South Asian Journal of Cancer 3 (2): 112–115.
American Cancer Society. 2011. Cancer facts & figures. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2011/cancer-facts-and-figures-2011.pdf. Accessed Dec 4 2017.
Ban, Kristen A., and Constantine V. Godellas. 2014. Epidemiology of breast cancer. Surgical Oncology Clinics of North America 23 (3): 409–422.
Barratt, Alexandra. 2015. Overdiagnosis in mammography screening: A 45 year journey from shadowy idea to acknowledged reality. BMJ: British Medical Journal. 350: h867. https://doi.org/10.1136/bmj.h867.
Bayer, Ron, and Amy L. Fairchild. 2016. Means, ends and the ethics of fear-based public health campaigns. Journal of Medical Ethics 42: 391–396.
Beckjord, Ellen B., Kerry A. Reynolds, G.J. van Londen, Rachel Burns, Reema Singh, Sarah R. Arvey, Stephanie A. Nutt, and Ruth Rechis. 2014. Population-level trends in posttreatment cancer survivors’ concerns and associated receipt of care: Results from the 2006 and 2010 LIVESTRONG surveys. Journal of Psychosocial Oncology 32 (2): 125–151.
Biller-Andorno, Nicola and Peter Jüni. 2014. Abolishing mammography screening programs? A view from the Swiss Medical Board. New England Journal of Medicine 370 (21): 1965–1967.
Blinder, Victoria, Carolyn Eberle, Sujata Patil, Francesca M. Gany, and Cathy J. Bradley. 2017. Women with breast cancer who work for accommodating employers more likely to retain jobs after treatment. Health Affairs 36 (2): 274–281.
Boyages, John, Senia Kalfa, Ying Xu, Louise Koelmeyer, Helen Mackie, Hector Viveros, Lucy Taksa, and Paul Gollan. 2016. Worse and worse off: The impact of lymphedema on work and career after breast cancer. SpringerPlus 5 (1): 657–664.
Breastscreen NSW. 2017. Cancer Institute New South Wales. https://www.breastscreen.nsw.gov.au/. Accessed Dec 4 2017.
Brennan, Meagan, and Nehmat Houssami. 2016. Discussing the benefits and harms of screening mammography. Maturitas 92: 150–153.
Carter, Stacy M., Jane Williams, Lucy Parker, Kristen Pickles, Gemma Jacklyn, Lucy Rychetnik and Alexandra Barratt. 2015. Screening for cervical, prostate, and breast cancer: Interpreting the evidence. American Journal of Preventive Medicine 49 (2): 274–285.
Carter, Stacy M., Christopher Degeling, Jennifer Doust, and Alexandra Barratt. 2016. A definition and ethical evaluation of overdiagnosis. Journal of Medical Ethics 42 (11): 705–714.
Clarke, Juanne N., and Michelle M. Everest. 2006. Cancer in the mass print media: Fear, uncertainty and the medical model. Social Science & Medicine 62 (10): 2591–2600.
Dartois, Laureen, Guy Fagherazzi, Laura Baglietto, Marie-Christine Boutron-Ruault, Suzette Delaloge, Sylvie Mesrine, and Francoise Clavel-Chapelon. 2016. Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: Estimates from the E3N-EPIC cohort. International Journal of Cancer 138 (10): 2415–2427.
Domenighetti, Gianfranco, Barbara D’Avanzo, Matthias Egger, Franco Berrino, Thomas Perneger, Paolo Mosconi and Marcel Zwahlen. 2003. Women’s perception of the benefits of mammography screening: Population-based survey in four countries. International Journal of Epidemiology 32 (5): 816–821.
Drageset, Sigrunn, Torill Christine Lindstrøm, and Kjell Underlid. 2016. “I just have to move on”: Women’s coping experiences and reflections following their first year after primary breast cancer surgery. European Journal of Oncology Nursing 21: 205–211.
Early Breast Cancer Trialists’ Collaborative Group. 2015. Aromatase inhibitors versus tamoxifen in early breast cancer: Patient-level meta-analysis of the randomised trials. The Lancet 386 (10001): 1341–1352.
Elmore, Joann G. 2016. Solving the problem of overdiagnosis. The New England Journal of Medicine 375 (15): 1483–1486.
Entwistle, Vikki, Stacy M. Carter, Lyndall Trevena, Kathy Flitcroft, Les Irwig, Kirsten McCaffery and Glen Salkeld. 2008. Communicating about screening. British Medical Journal 337:a1591.
Gernaat, S., P. Ho, N. Rijnberg, M. Emaus, L. Baak, M. Hartman, D. Grobbee, and H. Verkooijen. 2017. Risk of death from cardiovascular disease following breast cancer: A systematic review. Breast Cancer Research and Treatment 164 (3): 537–555.
Ghanouni, Alex, Susanne F. Meisel, Jolyn Hersch, Jo Waller, Jane Wardle and Cristina Renzi. 2016. Information on’overdiagnosis’ in breast cancer screening on prominent United Kingdom-and Australia-oriented health websites. PLoS ONE 11 (3): e0152279.
Gigerenzer, Gerd. 2015. Towards a paradigm shift in cancer screening: Informed citizens instead of greater participation. BMJ: British Medical Journal 350: h2175.
Hersch, Jolyn, Jesse Jansen, Les Irwig, Alexandra Barratt, Hazel Thornton, Kirsten Howard, and Kirsten McCaffery. 2011. How do we achieve informed choice for women considering breast screening? Preventive Medicine 53 (3): 144–146.
Hersch, Jolyn, Jesse Jansen, Alexandra Barratt, Les Irwig, Nehmat Houssami, Kirsten Howard, Haryana Dhillon and Kirsten McCaffery. 2013. Women’s views on overdiagnosis in breast cancer screening: A qualitative study. British Medical Journal 346:f158.
Hersch, Jolyn, Alexandra Barratt, Jesse Jansen, Les Irwig, K. McGeechan, Gemma Jacklyn, Hazel Thornton, Haryana Dhillon, Nehmat Houssami and Kirsten McCaffery. 2015. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: A randomised controlled trial. The Lancet 385 (9978): 1642–1652.
Hofmann, Bjorn. 2014. Diagnosing overdiagnosis: Conceptual challenges and suggested solutions. European Journal of Epidemiology 28: 599–604.
Howson, Alexandra. 1998. Embodied obligation: The female body and health surveillance. In The body in everyday life, eds. S. Nettleton, and J. Watson, 218–241. London: Routledge.
Jørgensen, Karsten J., Mette Kalager, Alexandra Barratt, Cornelia Baines, Per-Henrik Zahl, John Brodersen, and Russell P. Harris. 2017. Overview of guidelines on breast screening: Why recommendations differ and what to do about it. The Breast 31: 261–269.
Keen, John D., and Karsten J. Jørgensen. 2015. Four principles to consider before advising women on screening mammography. Journal of Women’s Health 24 (11): 867–874.
Kummerow, Kristy L., Liping Du, David F. Penson, Yu Shyr, and Mary A. Hooks. 2015. Nationwide trends in mastectomy for early-stage breast cancer. JAMA Surgery 150 (1): 9–16.
Lindberg, Laura G., Mette Svendsen, Mikala Dømgaard, and John Brodersen. 2013. Better safe than sorry: A long-term perspective on experiences with a false-positive screening mammography in Denmark. Health, Risk & Society 15 (8): 699–716.
Lupton, Deborah. 1995. The imperative of health: Public health and the regulated body. vol. 90. London: Sage Publications.
Mackenzie, Catriona, Wendy Rogers and Susan Dodds. 2014. Vulnerability: New essays in ethics and feminist philosophy. Oxford: Oxford University Press.
Marmot, Michael G. 2012. The benefits and harms of breast cancer screening: An independent review. The Lancet 380 (9855): 1778–1786.
Mehnert, Anja. 2011. Employment and work-related issues in cancer survivors. Critical Reviews in Oncology/Hematology 77 (2): 109–130.
Myers, Evan R., Patricia Moorman, Jennifer M. Gierisch, Laura J. Havrilesky, Lars J. Grimm, Sujata Ghate, Brittany Davidson, Ranee C. Mongtomery, Matthew J. Crowley, Douglas C. McCrory, Amy Kendrick and Gillian Sanders. 2015. Benefits and harms of breast cancer screening: A systematic review. Journal of the American Medical Association 314 (15): 1615–1634.
Nelson, Heidi D., Rochelle Fu, Amy Cantor, Miranda Pappas, Monica Daeges, and Linda Humphrey. 2016. Effectiveness of breast cancer screening: Systematic review and meta-analysis to update the 2009 US preventive services task force recommendation effectiveness of breast cancer screening. Annals of Internal Medicine 164 (4): 244–255.
NHMRC. 2007. National Statement on Ethical Conduct in Human Research 2007 (Updated May 2015). National Health and Medical Research Council, Australian Research Council and Australian Vice-Chancellors’ Committee Canberra, ACT.
Nomura, Sarah J., Maki Inoue-Choi, DeAnn Lazovich and Kim Robien. 2016. WCRF/AICR recommendation adherence and breast cancer incidence among postmenopausal women with and without non-modifiable risk factors. International Journal of Cancer 138 (11): 2602–2615.
Ozakinci, Gozde, Aleksandra Sobota, and Gerry Humphris. 2014. Fear of cancer recurrence among breast cancer survivors. Current Breast Cancer Reports 6 (3): 219–225.
Paci, Eugenio. 2012. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. Journal of Medical Screening 19 (Suppl 1): 5–13.
Parker, Lisa M., and Stacy M. Carter. 2016. The role of socially embedded concepts in breast cancer screening: An empirical study with Australian experts. Public Health Ethics 9 (3): 276–289.
Parker, Lisa M., Lucy Rychetnik, and Stacy M. Carter. 2015. The role of communication in breast cancer screening: A qualitative study with Australian experts. BMC Cancer 15 (1): 741.
Ploug, Thomas, Soren Holm, and John Brodersen. 2012. To nudge or not to nudge: Cancer screening programmes and the limits of libertarian paternalism. Journal of Epidemiology and Community Health 66: 1193–1196.
Quanstrum, Kerrianne H., and Rodney A. Hayward. 2010. Lessons from the mammography wars. The New England Journal of Medicine 363 (11): 1076–1079.
Rogers, Wendy A., and Yishai Mintzker. 2016. Getting clearer on overdiagnosis. Journal of Evaluation in Clinical Practice 22: 580–587.
Rogers, Wendy, Catriona Mackenzie and Susan Dodds. 2012. Why bioethics needs a concept of vulnerability. International Journal of Feminist Approaches to Bioethics 5 (2): 11–38.
Rogers, Wendy, Wendy Craig, and Vikki Entwistle. 2017. Ethical issue raised by thyroid cancer overdiagnosis: A matter of public health? Bioethics 31 (8): 590–598.
Schwartz, Lisa M., Steven Woloshin, Floyd J Fowler Jr., and H. Gilbert Welch. 2004. Enthusiasm for cancer screening in the United States. Journal of the American Medical Association 291 (1): 71–78.
Silverman, E., Steven Woloshin, Lisa Schwartz, S. Byram, H. Gilbert Welch, and B. Fischhoff. 2001. Women’s views on breast cancer risk and screening mammography: A qualitative interview study. Medical Decision Making 21 (3): 231–240.
Sisti, Julia S., Laura C. Collins, Andrew H. Beck, Rulla M. Tamimi, Bernard A. Rosner and A. Heather Eliassen. 2016. Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses’ health studies. International Journal of Cancer 138 (10): 2346–2356.
Sun, Yuanlu, Cheryl L. Shigaki, and Jane M. Armer. 2017. Return to work among breast cancer survivors: A literature review. Supportive Care in Cancer 25 (3): 709–718.
van Agt Heleen, Jacques Fracheboud, Annemieke van der Steen and Harry de Koning. 2012. Do women make an informed choice about participating in breast cancer screening? A survey among women invited for a first mammography screening examination. Patient Education and Counseling 89 (2): 353–359.
Vickberg, Suzanne M. J. 2003. The Concerns About Recurrence Scale (CARS): A systematic measure of women’s fears about the possibility of breast cancer recurrence. Annals of Behavioral Medicine 25 (1): 16–24.
Walker, Mary J., and Wendy A. Rogers. 2017a. Reasonableness, credibility, and clinical disagreement. AMA Journal of Ethics 19 (2): 176–182.
Walker, Mary J., and Wendy A. Rogers. 2017b. Diagnosis, identity, and the experience of asymptomatic disease. Theoretical Medicine and Bioethics 38 (4): 307–321.
Waller, Jo, Katy Osborne, and Jane Wardle. 2015. Enthusiasm for cancer screening in Great Britain: A general population survey. British Journal of Cancer 112 (3): 562–566.
Wegwarth, Odette, and Gerd Gigerenzer. 2013. Overdiagnosis and overtreatment: Evaluation of what physicians tell their patients about screening harms. JAMA Internal Medicine 173 (22): 2086–2088.
Welch, H. Gilbert, and Honor J. Passow. 2014. Quantifying the benefits and harms of screening mammography. JAMA Internal Medicine 174 (3): 448–454.
Welch, H. Gilbert, Lisa M. Schwartz and Steven Woloshin. 2011. Overdiagnosed: Making people sick in the pursuit of health. Boston: Beacon Press.
Welch, H., Philip C. Gilbert, A. Prorok, James, O’Malley, and Barnett S. Kramer. 2016. Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. New England Journal of Medicine 375 (15): 1438–1447.
Willis, Karen. 2004. Personal choice/social responsibility: Women aged 40–49 years and mammography screening. Journal of Sociology 40 (2): 121–136.
World Health Organization. 2013. Women’s health. Geneva: World Health Organization. http://www.portal.pmnch.org/mediacentre/factsheets/fs334/en/. Accessed Dec 4 2017.
Yin, Wesley, Ruslan Horblyuk, Julia J. Perkins, Steve Sison, Greg Smith, Julia T. Snider, Yanyu Wu, and Tomas J. Philipson. 2017. Association between breast cancer disease progression and workplace productivity in the United States. Journal of Occupational and Environmental Medicine 59 (2): 198–204.